AP01

날짜

2027년 6월 추정

대상 질환

폐섬유증; 진행성 폐섬유증; Pulmonary Fibrosis Secondary to Systemic Sclerosis; Pulmonary Fibrosis, Interstitial Lung Disease; 간질성 폐질환; Interstitial Lung Disease Due to Connective Tissue Disease (Disorder); Interstitial Lung Disease in Patients With Rheumatoid Arthritis; Interstitial Lung Disease With Progressive Fibrotic Phenotype in Diseases Classified Elsewhere; Hypersensitivity Pneumonitis; Interstitial Lung Disease With Systemic Sclerosis

단계

임상 결과 발표 예정

출처

ClinicalTrials.gov NCT06329401 (새 창)